← All companies

Rhythm Pharmaceuticals

Healthcare & Life Sci

Company overview

Rhythm Pharmaceuticals is a global biopharmaceutical company that develops treatments for rare neuroendocrine diseases. Its main product is IMCIVREE (setmelanotide), an injectable medicine that treats hyperphagia and obesity in patients with rare genetic conditions such as Bardet-Biedl syndrome. The company was founded in Boston in 2008 and is headquartered there. It is a publicly traded company. Rhythm Pharmaceuticals is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
United States

Filters

Create your account

Create an account to save jobs and track applications.